Presented by Tamara Meyers-Laplace, MSN, RN; Dean Engle, BSN, RN

No relevant disclosures. 

1.00 AACVPR CEUs, 1.00 ANCC CEUs pending

Description: Advancements in cardiac and other implantable medical devices have led to increased complexity—and sometimes visual similarity—among various technologies. This webinar will help attendees improve their ability to identify implantable cardiac rhythm management (CRM) devices, gain a general understanding of their functionality and how they differ from other implants, and explore the mechanisms of action for various rate response sensor types, particularly in the context of physical activity.

Learning Objectives: 

1. Identify and differentiate common types of implantable cardiac devices (e.g., pacemakers, ICDs, CRT devices) by interpreting key device markers and recognition techniques relevant to cardiac rehabilitation settings.
2. Describe current pacing strategies, including traditional right ventricular pacing and newer approaches such as conduction system pacing (His bundle and left bundle branch pacing), and explain their clinical implications for exercise programming.
3. Explain the function and types of rate-responsive sensors used in modern implantable devices (e.g., accelerometer-based, minute ventilation, blended sensors), including how these sensors modulate heart rate during physical activity.
4. Evaluate how various physical activities influence rate response sensors, and identify which movements or exercise modalities may under- or over-stimulate these sensors, potentially impacting exercise tolerance and safety devices, ensuring optimal cardiovascular response and patient safety in cardiac rehabilitation programs.

Presented by: Wendy K. Cawley, BSN, RN, CCRP; Melissa Lyle, MD, FACC, FHFSA

No relevant disclosures. 

1.00 AACVPR CEUs, 1.00 ANCC CEUs pending

Description: This webinar will provide an overview of current practices and advancements in heart failure and heart transplantation, and how to best serve these specific patient populations to maximize health outcomes. The practical management of these patients within the cardiac rehab setting will be discussed, including assessment, exercise, nutrition, psychosocial needs, medication management, blood glucose monitoring, infection control, rejection, and long-term self-monitoring. 

Learning Objectives:  

1. Discuss the various treatment options for patients with advanced heart failure and recognize the importance of pre-rehabilitation prior to those advanced therapies.

2. Describe how CP Rehab staff can help patients with LVADs optimize their health with lifestyle adjustments.

3. Recognize the special considerations needed in managing heart recipients and how those considerations can be applied in the CP Rehab setting.

Presented by Megan Hays, PhD, ABPP, FAACVPR

Description: This webinar, recorded in June 2025, will explore the complex relationship between obesity, behavior change, and cardiovascular health, equipping multidisciplinary cardiac and pulmonary rehabilitation professionals with strategies to enhance patient care. Dr. Megan Hays will discuss social determinants of health, weight bias, gut-brain connections, and the psychological impact of obesity, providing insights into overcoming exercise apprehension and improving adherence. Attendees will gain practical tools to support behavior change, reduce cardiovascular risk, and foster a more inclusive, patient-centered rehabilitation experience. Join us for this essential discussion on empowering patients in their journey to better heart health.

Learning Objectives: 

1. Clarify the contributions of social determinants of health, weight bias, and various behaviors to body weight.
2. Learn evidence-based practical approaches to address exercise apprehension, enhance adherence, and support sustainable lifestyle modifications to improve cardiovascular well-being.
3. Develop strategies to provide sensitive, patient-centered care for individuals with obesity, ensuring a supportive rehabilitation environment that promotes long-term cardiovascular health.

There is a 60-day viewing window for the recordings. This presentation series is sponsored by Novo Nordisk, Inc. This presentation is not offered for credits (CEUs).

Presented by Brenna VanFrank, MD, MPH
No relevant disclosures. 

1.0 AACVPR CEUs.

Description: The emergence of e-cigarettes in the tobacco product landscape has shifted clinical and public health approaches to tobacco prevention and control. While much is known about e-cigarettes, many questions remain about their health and public health implications. In this webinar, released as a recorded webinar in 2020, participants will gain an understanding about what e-cigarettes are, who is using e-cigarettes and why, and what current evidence we have regarding the health impact of e-cigarette use. Clinical and public health approaches to e-cigarettes and other emerging tobacco products will additionally be discussed.

Learning Objectives: 

1. Identify the types of e-cigarettes and the substances they contain
2. Describe e-cigarette use patterns and the potential health impacts of e-cigarette use
3. Discuss clinical and public health approaches to emerging tobacco products

Viewing window: 60 days from date of purchase

Presented by Ana Mola, PhD, RN, ANP C, MAACVPR; Quinn R. Pack, MD, MSc, FAACVPR; Shelley S. Hammond, MMC
No relevant disclosures.

1.0 AACVPR CEUs

Description: Tobacco use, especially cigarette smoking, is a major risk factor for cardiovascular and pulmonary morbidity and mortality. Comprehensive tobacco treatment is a critical component of the clinical care for individuals with or at risk for cardio/pulmonary disease, as well as peripheral arterial disease (PAD). This session, released as a recorded webinar in 2020, will provide an overview of tobacco treatment within the rehab setting, and discuss how to utilizes tools and resources developed from the Tips From Former Smokers® campaign.

Learning Objectives:

1. Review nicotine addiction physiology and how this impacts clinical treatment
2. Summarize the tobacco cessation evidence based medication therapy and brief counseling interventions
3. Discuss the key components of operationalizing a tobacco treatment program, within a variety of rehabilitation settings.
4. Explore approaches for CR

Viewing window: 60 days from date of purchase

Presented by Virend K. Somers, MD, PhD; Naima Covassin, PhD

No relevant disclosures. 

1.00 AACVPR CEUs, 1.00 ANCC CEUs 

Description: The presenters will provide an overview of sleep apnea epidemiology, clinical presentation and cardiovascular implications. Additionally, they will also discuss how sleep disorders may impact cardiac rehabilitation outcomes. 

Learning Objectives:  

1. To review the prevalence and cardiovascular implications of sleep apnea. 
2. To explore the effects of sleep apnea therapy on cardiovascular outcomes.
3. To examine how sleep disorders may impact patients undergoing cardiac rehabilitation. 

Presented by: Michael See, MS, CDCES, ACSM-CEP, NBC-HWC

No relevant disclosures. 

1.00 AACVPR CEUs, 1.00 ANCC CEUs 

Description: Diabetes is a complex and prevalent condition in populations eligible for cardiopulmonary rehabilitation (CR). A significant disparity exists in the uptake and adherence of CR programs between people with and without diabetes. This webinar, recorded in May 2025, will update CR practitioners to factors associated with increased cardiovascular risk, patient assessment strategies, advances in diabetes-related technology, and recommendations for improving participation outcomes and optimizing glycemic control around exercise. 

Learning Objectives: 

The learner will be able to describe the different types of diabetes and summarize different approaches to patient evaluation and assessment. 
The learner will explain the challenges and opportunities that people living with diabetes experience when participating in cardiopulmonary rehabilitation.
The learner will explain the seven diabetes self-care behaviors and how they can help their patients improve their self-management. 
The learner will discuss various diabetes-related technologies and their use in optimizing glycemic control in the CR settings.

Presented by Dr. Carl J. Lavie, MD

Description: During this presentation, recorded as a live webinar in May 2025, Dr. Lavie will review the adverse effects of obesity and cardiovascular disease risk factors and to increase the prevalence of cardiovascular disease. He will discuss the main factors that increase obesity in the first place, including fast foods, sugary beverages, but especially the progressive fall in physical activity over 5 decades. This presentation will define the obesity paradox and how this is impacted by physical activity and fitness and will describe the increase in cardiometabolic diseases associated with obesity and potential benefits of cardiac rehabilitation.

Learning Objectives:

1. Describe the adverse effects of obesity to increase CVD risk factors and prevalence of CVD.
2. Summarize the obesity paradox and how this is impacted by physical activity and fitness.
3. Describe the increase in cardiometabolic diseases and potential benefits of cardiac rehabilitation.

Viewing Window: There is a 60-day viewing window for the recordings. 

This presentation series is sponsored by Novo Nordisk, Inc. This presentation is not offered for credits (CEUs).

Presented by Laura Suarez Pardo, MD

This session, recorded in April 2025,  explores the evolution and impact of psychocardiology, highlighting its emergence as a critical field addressing the intersection of cardiovascular disease (CVD) and psychological distress. Participants will gain insights into key psychosocial stressors affecting CVD patients and learn how to apply screening tools and both pharmacologic and non-pharmacologic interventions to improve patient outcomes. Additionally, the session will emphasize the integration of psychosocial care into cardiac and pulmonary rehabilitation, underscoring its essential role in the early detection and management of mental health conditions to enhance overall cardiovascular and pulmonary health.

Learning Objectives: 

1. Explore the historical development of psychocardiology and its role in addressing psychological distress in patients with cardiovascular disease (CVD).  
2. Recognize and Manage Psychosocial Distress in CVD – Identify key areas of psychological distress in patients with CVD and review available screening tools, pharmacologic, and non-pharmacologic treatment strategies.  
3. Integrate Psychosocial Care into Cardiac/Pulmonary Rehabilitation (CPR) – Examine the core components of psychosocial management in CPR and its critical role in the early detection and intervention of mental health conditions.  

Viewing window: 60 days from date of purchase. 

Presented by: Carmen M. Terzic, MD, PhD

1.00 AACVPR CEUs; 1.00 ANCC CEUs 

Description: In this session, released as a webinar in March 2025, discusses frailty, presented by Dr. Carmen Terzic. Frailty is a biological syndrome that reflects a state of decreased physiological reserve, function and increased vulnerability to stressors. Frailty is associated with higher mortality, disability, and hospitalization in the cardiac population. It is critical to identify frail and vulnerable patients and adapt their assessment and intervention plan within the frame of primary and secondary prevention of CVDs. Cardiac rehab is well positioned to counteract frailty and its consequences.

Learning Objectives: 

1. Define frailty
2. Discuss available tools to assess frailty 
3. Describe frailty and its relationship with cardiovascular diseases
4. Discuss the management of frailty in cardiac rehabilitation (CR)

Viewing window: 60 days from date of purchase.